Aguilar Laura K. 4

4 · Candel Therapeutics, Inc. · Filed May 10, 2022

Form 4

Period: 2022-05-06

10% Owner

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−76,717→ 0 total
Exercise: $1.46Exp: 2028-11-13→ Common Stock (76,717 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−76,717→ 0 total
Exercise: $1.46Exp: 2028-11-13→ Common Stock (76,717 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−17,901→ 0 total
Exercise: $1.46Exp: 2028-08-17→ Common Stock (17,901 underlying)
Exercise/Conversion
Common Stock
2022-05-06$1.46/sh+171,335$250,149→ 1,102,374 total
Tax Payment
Common Stock
2022-05-06$3.65/sh−68,534$250,149→ 1,033,840 total

Holdings

Footnotes (5)

[F1]Includes 32,399 shares of common stock held jointly with spouse.
[F2]Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share.
[F3]Shares held by the Laura K. Aguilar 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.
[F4]This option is fully vested and exercisable as of the date hereof.
[F5]Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable.

Documents

1 file